NEW TEST: the anti-eyebags EYESERYL® peptide, now proved in men
Up to 29.7% reduction in the under-eyebags volume in 28 days, was shown in the recently performed clinical test on male volunteers, building on what the well-known tetrapeptide can offer to eye-care formulations.
Research suggest that men are more prone than women to have eyebags related to lipids due to fat protrusion.
The clinical study has been performed on male volunteers aged 30-65 years who applied a cream with 1% EYESERYL® peptide solution B on one eye contour and a placebo cream on the other, twice a day for 28 days. The significant decrease of the volume of eyebags was visible after 14 days with up to 29.7% reduction after 28 days. 90% of the subjects stated in a self-evaluation that they would recommend the product as an efficient anti-eyebag treatment.
Multiple reasons to be on the news
EYESERYL® peptide presents a brand-new image (above), more aligned with the updated product profile and the recent clinical findings.
Launched for the first time in 2004, the peptide soon was honored by the cosmetic market, receiving the Cosmetics and Toiletries award in 2005 for is efficacy in improving the under-eye region by targeting eyebags, dark circles and skin damage.